PDF herunterladen
Synfacts 2010(5): 0506-0506  
DOI: 10.1055/s-0029-1219649
Synthesis of Natural Products and Potential Drugs
© Georg Thieme Verlag Stuttgart ˙ New York

Synthesis of (R)-Olodaterol

Contributor(s): Philip Kocienski
T. Bouyssou, C. Hoenke, K. Rudolf, P. Lustenberger, S. Pestel, P. Sieger, R. Lotz, C. Heine, F. H. Büttner, A. Schnapp, I. Konetzki*
Boehringer Ingelheim Pharma GmbH & Co., Biberach, Germany
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
22. April 2010 (online)

   Lizenzen und Reprints

Significance

Olodaterol is a potent agonist of the human β2-adrenoceptor with a high β1/β2 selectivity. Its crystalline hydrochloride salt is suitable for inhalation and is currently undergoing clinical trials in man for the treatment of asthma. Oloda­terol has a duration of action that exceeds 24 hours in two preclinical animal models of bronchoprotection and it has a better safety margin compared with formoterol.